ClinicalTrials.gg
Enrolling by invitationNCT04834427Updated Mar 8, 2024

Safety and Efficacy Evaluation of S (+) - Ketamine in Children

A Phase 4 interventional study of Conventional therapy + S (+)-Ketamine and Conventional therapy in S-ketamine, Esketamine and Acute Pain, sponsored by Chinese PLA General Hospital. Enrolling by invitation at 1 site in China. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2024-03-08.

Sponsored by Chinese PLA General Hospital · Phase 4, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as enrolling by invitation.
Phase
Phase 4
Study type
Interventional
Enrollment
3,000
Allocation
Randomized
Ages
Up to 17 Years
Sex
All
01

Study summary

A multicenter, randomized, open-label, active controlled pragmatic clinical trial that evaluates the safety and efficacy of S (+) -ketamine for postoperative acute pain in children in perioperative settings.

Read the detailed description

Children often suffer acute pain,awakening delirium, anxiety and depression after operation which may affect the recovery of children. S (+) - ketamine has been described to decrease acute pain and opioid consumption,but it needs to confirm for chinese children undergoing surgery.

Objective:

To evaluate the analgesic effect of perioperative administration of S (+) - ketamine on postoperative acute pain in children undergoing surgery, and explore the effects of S (+) - ketamine on postoperative awakening delirium, postoperative anxiety and depression mood ,as well find the best usage, including dose, timing, compatibility, and type of operation.

02

Conditions studied

  • S-ketamine
  • Esketamine
  • Acute Pain
  • Postoperative Pain
  • Analgesia
  • Hyperalgesia
  • Delirium
  • Depression, Anxiety
  • Children
03

In context

Acute Pain

1,073 studies on the registry are indexed under Acute Pain; 166 are open to participants now.

This study's planned enrollment of 3,000 is above the median of 86 across 902 interventional studies indexed under Acute Pain.

Browse Acute Pain studies →

Lead sponsor

Chinese PLA General Hospital is the lead sponsor of 570 studies on the registry; 207 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age ≤17 years;
  2. Scheduled for elective digestive tract surgery, orthopedic surgery, urological surgery , ear surgery or other surgeries under general anesthesia;
  3. I~Ⅲ;
  4. The form was signed by the patients or the guardians.

Exclusion criteria

Exclusion Criteria:

  1. The expected length of hospital stay of the patient is less than 48h;
  2. Patients expected to be admitted to the ICU after surgery;
  3. Patients expected to return to the ward with tracheal catheter after surgery;
  4. Be allergic to S (+) - ketamine;
  5. Patients with severe disorder of consciousness or mental system diseases (schizophrenia, mania, bipolar disorder, psychosis, etc.) or cognitive dysfunction;
  6. Patients with congenital heart disease or severely developmental retardation;
  7. Patients with any of the following of S (+) - ketamine:

    1. Patients with risk of serious rise of blood pressure or intracranial pressure;
    2. Patients with high intraocular pressure (glaucoma) or penetrating ocular trauma;
    3. Patients with poorly controlled or untreated hypertension (Resting systolic blood pressure greater than 180 mmHg, or resting diastolic blood pressure greater than 100mmHg);
    4. Patients with untreated or undertreated hyperthyroidism.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
3,000 participants (estimated)

Study arms

  • Experimental
    S (+)-Ketamine group

    Patients who undergo general anesthesia using S(+)-ketamine hydrochloride for anesthesia induction, maintenance or postoperative analgesia.

    Drug: Conventional therapy + S (+)-Ketamine

  • Active comparator
    Control group

    Patients who undergo conventional therapy without S (+)-Ketamine hydrochloride injection during perioperative period.

    Drug: Conventional therapy

Interventions

  • DrugConventional therapy + S (+)-Ketamine

    Drug page: Esketamine

    In principle, there are no specific restrictions on the dosage, mode of administration, timing, and compatibility of S-ketamine hydrochloride injection, but the recommended dosage is given, which is lower than the dosage specified in the instructions. Recommended use and dosage of S (+)-Ketamine: 1. Intravenous injection:Bolus intravenous injection before skin incision, the dose is 0.1\~0.25 mg/kg; Bolus intravenous injection (dose 0.1\~0.25 mg/kg) before skin incision + continuous intravenous infusion (dose of 0.1\~0.25 mg/kg/h) during operation; Continuous intravenous infusion after surgery with a dose of 0.02\~0.1 mg/kg/h for 24\~48 h. 2. Intramuscular injection:The dose is 2\~4 mg/kg.

    Also known as: Conventional therapy + S-ketamine, Conventional therapy + Esketamine

  • DrugConventional therapy

    Receiving conventional therapy without S (+)-Ketamine hydrochloride injection. There is no restrictions in drugs, doses and incompatibility, the researchers can choose appropriate medication regimens based on clinical practice, but other NMDA receptor antagonists are not be allowed to use, such as dextromethorphan and amantadine.

    Also known as: Routine treatment

06

What researchers measure

Primary outcomes

  1. The area under the broken line of FLACC scale score

    Only for children aged 0\~7 years. The score of FLACC Scale is 0-10, the higher the score, the more severe the pain.

    Time frame: Hour 0-48 after surgery

  2. The area under the broken line of Numerical Rating Scale score

    Only for children aged 8\~17years. The score of Numerical Rating Scale(NRS) is 0-10, the higher the score, the more severe the pain.

    Time frame: Hour 0-48 after surgery

  3. Opioid consumption

    Total opioid consumption(conversion to equivalent morphine)

    Time frame: Hour 0-48 after surgery

Other outcomes

  1. FLACC scale score

    Only for children aged 0\~7 years. The score of FLACC Scale is 0-10, the higher the score, the more severe the pain. 8≤Age ≤17 years: NRS pain score at 2h, 4h, 24h, 48h after surgery.

    Time frame: Hour 0-48 after surgery

  2. Numerical Rating Scale score

    Only for children aged 8\~17years. The score of Numerical Rating Scale(NRS) is 0-10, the higher the score, the more severe the pain.

    Time frame: Hour 0-48 after surgery

  3. Time of first rescue analgesia

    The time from the end of the operation to the first rescue analgesics after the operation. Rescue analgesia refers to the analgesia according to the patient's or guardian's requirements in addition to routine postoperative analgesia.

    Time frame: Hour 0-48 after surgery

  4. The incidence of rescue analgesia

    Rescue analgesia refers to the analgesia according to the patient's or guardian's requirements in addition to routine postoperative analgesia.

    Time frame: Hour 0-48 after surgery

  5. Recovery time

    The time from the end of the operation to recovery(can be awakened)

    Time frame: Day 0

  6. The incidence of emergence delirium

    Only for children aged 0-7 years. Evaluating by the Pediatric Emergence Delirium Rating Scale(PAED) ,the score of the scale is 0\~20, when the total score is greater than 10, it is considered that the child has delirium.The scale will be evaluated 10minutes, 20minutes, 30minutes after extubation.

    Time frame: Day 0

  7. The incidence of unexpected intraoperative events

    Unexpected events during operation include intraoperative cough, laryngeal spasm, body movement, tachycardia, decreased oxygen saturation, respiratory depression, bradycardia, hypertension and hypotension.

    Time frame: Intraoperative

  8. The incidence of adverse events after surgery

    The incidence of adverse events from the end of the operation to 48h after surgery. Including nausea, vomiting, increased secretions, dizziness, oversedation, infection,anesthetic awareness, nightmares, restlessness, pruritus, disorientation, delirium, respiratory depression, diplopia, diarrhea, intestinal obstruction, urinary retention, gastroesophageal reflux, constipation, chills, hallucinations, etc.

    Time frame: Hour 0-48 after surgery

  9. Children's Depression Inventory(CDI) score

    Only for children aged 8\~17.Children's Depression Inventory(CDI) scale include 27 questions ,from 0 to 54pionts, the higher the score, the more severe the depressive symptoms.

    Time frame: Hour 48 after surgery

  10. Hospital Anxiety and Depression Scale(HAD)score

    Only for children aged 14\~17.Hospital Anxiety and Depression Scale(HAD)include anxiety measure(7 questions,0-21pionts) and depression measure(7 questions,0-21pionts),the higher the score, the more severe the symptoms.

    Time frame: Hour 48 after surgery

  11. Pharmacoeconomic indicators

    Calculating incremental cost-effectiveness ratio (ICER)based on cost-effectiveness analysis.

    Time frame: Hour 48 after surgery

07

Study locations

1 site
08

References and documents

Publications

  • Wang H, Duan C, Zhang J, Qu S, Sun Y, Zhou L, Yang L, Lan C, Mi W, Chen P. Evaluation of the effect of perioperative administration of S(+)-ketamine hydrochloride injection for postoperative acute pain in children: study protocol for a prospective, multicenter, randomized, open-label, parallel-group, pragmatic clinical trial. Trials. 2022 Jul 23;23(1):586. doi: 10.1186/s13063-022-06534-z. PubMed 35870990 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2022 (actual). Primary completion is estimated for Dec 2024, 31 months after the start.

Of 79 non-industry phase 4 interventional studies under Acute Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 32. This study's planned 31 months is above that.

Counting every sponsor, half of 84 studies reached it within 19 months; a quarter within 9 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 2, 2021
First posted
Apr 8, 2021
StartActual
Apr 20, 2022
Primary completionEst.
Dec 1, 2024
CompletionEst.
Dec 4, 2024
Last update
Mar 8, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04834427
Collaborators
Southern Medical University, China, Beijing Children's Hospital, Shanghai Children's Medical Center, Hunan Children's Hospital
Responsible party
Weidong Mi (Director of the Department of Anesthesiology, Chinese PLA General Hospital, Chinese PLA General Hospital) — Principal investigator
First posted
Apr 8, 2021
Start date
Apr 20, 2022
Primary completion
Dec 1, 2024 (estimated)
Completion
Dec 4, 2024 (estimated)
Last update
Mar 8, 2024

Study contacts

Weidong Mi, MD
study chair · Chinese PLA General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Esketamine

Start the discussion